Circulating tumor DNA (ctDNA) for mol... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Circulating tumor DNA (ctDNA) for molecular residual disease (MRD) blood test

Pcnmyy profile image
9 Replies

Hello Friends, I was searching for a test (other than scans and PSA) that detects solid tumors circulating in the blood and I came across the ctDNA for molecular residual disease (MRD) blood test offered by Signatera for Colorectal Cancer. Has anyone had this test to diagnose or to detect Prostate Cancer while in remission? Is it FDA approved for Prostate Cancer? How accurate it is? Thanks.

Written by
Pcnmyy profile image
Pcnmyy
To view profiles and participate in discussions please or .
Read more about...
9 Replies
Darryl profile image
DarrylPartner

These two videos might help you with some background Molecular Biomarkers for Prostate Canceryoutu.be/KogGTOqYduM

And

Can Liquid Biopsies Replace Surgical Biopsies?

youtu.be/J04iWxvnvwM

Pcnmyy profile image
Pcnmyy in reply to Darryl

Thank you for the videos.

The second guy says there’s a Foundation test and a Guardian test. No mention of a Signatera test. Suggest you coordinate with your MO to get one of those two, or coordinate with Foundation One.

Pcnmyy profile image
Pcnmyy in reply to

Thank you for your reply. Well, I am aware of the two tests you mentioned. The test I am talking about detects the circulating DNA of solid tumors in blood stream. It doesn't examine genes mutations of tumors' cells as explained in Signatera website (natera.com/oncology/signate.... I also understood that the test is very effective in detecting residual disease in Colorectal Cancer patients. I am wondering if this test can be used also to detect residual disease for Prostate Cancer patients when their PSA stays undetectable for a long period of time, and somehow it can be used to conclude that the patient is cured or at least can safely start ADT vacation. I will raise these questions with my MO in my next visit in early Feb. 2022. Thanks

in reply to Pcnmyy

I will raise it too!

tallguy2 profile image
tallguy2

I will add to the conversation that no circulating tumor cells were detected in my blood until quite recently…last summer. The rest of the time the results were negative. So if the DNA test you refer to requires that there be CTCs you could miss out on a diagnosis that should include scans.

Pcnmyy profile image
Pcnmyy in reply to tallguy2

Hello tallguy2,The test I am referring to is a blood test that detects the circulating DNA of solid tumors in blood stream. Please see the description at: (natera.com/oncology/signate....

They say it is different from the gene mutation test offered by Foundation One and is effective in detecting new and residual Colorectal Cancer.

in reply to Pcnmyy

I read a comment by an MO that I am familiar with that looked forward to the day that cfDNA will replace scans. I guess it just isn't here yet with prostate cancer but i intend to question that MO about it in a few days. Those other tests you cited to look enourmously accurate.

Pcnmyy profile image
Pcnmyy in reply to

Thank you for the updated info. Please let us know what your MO say about this test.

You may also like...

Does the new Circulating Tumor DNA blood test have any use for APCa patients?

personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular...

Circulating Tumor Cells & Inflammation

(NLR), platelet-lymphocyte ratio (PLR), and circulating tumor cells (CTCs) have been associated...

There's 1-10 Circulating Tumor Cells (CTC) per mL of whole blood. So why liquid biopsies are not common?

com/diagnostics/articles/circulating-tumor-cells-detection-and-applications-333566 A Google search...

Game changer in diagnosis?

differentiate between localized prostate cancer and metastatic prostate cancer, even detecting...

Blood Test Parameters

for monitoring Prostate Cancer. My GP is hopeless, and the urologists only check PSA. My CRP is high